Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI aims to uncover hidden barriers to stroke care

NCT ID NCT07257146

Knowledge-focused Sponsor: Middle East North Africa Stroke and Interventional Neurotherapies Organization Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at 250 stroke patients to understand why some arrive late at the hospital. Researchers use a questionnaire, mapping tools, and brain scans to find social, transport, and knowledge barriers. A machine learning model will try to predict who is at risk for delay, with the goal of improving emergency stroke care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Targeted Stroke Systems of Care Training (SABI-Guided)
What this could lead to
If successful, this could help hospitals identify and reduce barriers that delay stroke patients from getting timely treatment, potentially saving lives.
What could go wrong
This is an observational study with historical controls, so results may not prove cause and effect. The machine learning model may not work well in other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The source population comprises patients recruited from 12 tertiary centers across the MENA region: Alexandria University, Ain Shams University, and Cairo University (Egypt); Eskisehir Osmangazi University and Dr. Lutfi Kirdar City Hospital (Turkey); Amman Specialized IR Center (Jordan); King Khalid University, King Abdullah Medical City, and Imam Abdulrahman Al Faisal University (Saudi Arabia); Institute National de Neurology (Tunisia); Cleveland Clinic Abu Dhabi (UAE); and Weill Cornell Medicine (Qatar). This multinational design ensures significant geographic heterogeneity-ranging from the dense urban traffic of Istanbul and Cairo to the mountainous terrain of Abha-which is critical for GIS transport analysis. Additionally, the inclusion of diverse economic and cultural backgrounds supports robust SABI analysis regarding stroke awareness and health-seeking behaviors across the region.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of Acute Ischemic Stroke (AIS) confirmed by neuroimaging (CT or MRI). Age $\\geq$ 18 years. Presentation to the Emergency Department within 7 days of symptom onset (to ensure recall accuracy). Patient or Legally Authorized Representative (LAR) able to provide informed consent. Verifiable residential address (required for GIS analysis). Exclusion Criteria: * In-hospital stroke onset. Stroke mimics (e.g., seizure, complex migraine, hypoglycemia). Hemorrhagic stroke. Homelessness or lack of fixed address (precludes geospatial analysis). Severe aphasia or cognitive deficit without an available surrogate/caregiver to complete the questionnaire.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute ischemic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthcare access Healthcare disparities Practice Stroke Thrombectomy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Alexandria Stroke and Neurointervention Center

    Alexandria, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.